A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-α administered as a 24-hour weekly infusion schedule in patients with advanced cancer

By Advani Ranjana   Lum Bert   Fisher George   Halsey Joanne   Geary Richard   Holmlund Jon   Kwoh T.   Dorr F.   Sikic Branimir  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 467-477

Springer Publishing Company

Access to resources Recommend Favorite

An acute i.c.v. infusion of leptin has no effect on hypothalamic histamine and tele-methylhistamine contents in Wistar rats

By Lecklin A.   Hermonen P.   Tarhanen J.   Mannisto P.T.  

European Journal of Pharmacology, Vol. 395, Iss. 2, 2000-04 ,pp. : 113-119

Elsevier

Access to resources Recommend Favorite

Body distribution of polysorbate‐80 and doxorubicin-loaded [ 14 C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

By Ambruosi Alessandra   Yamamoto Hiromitsu   Kreuter Jörg  

Journal of Drug Targeting, Vol. 13, Iss. 10, 2005-01 ,pp. : 535-542

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Chronopharmacokinetics of cyclosporine A following a single i.v. dose in the Wistar rat

By Malmary M.F.   Houti I.   Labat C.   Batalla A.   Moussamih S.   Bouguettaya D.   Oustrin J.   Houin G.  

European Journal of Pharmaceutical Sciences, Vol. 3, Iss. 1, 1995-02 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite